CA
Cormorant Asset Management, LP cut its BIOA stake below 5%
Cormorant Asset Management, LP reported owning 4.9% of BioAge Labs, Inc. (BIOA) (2,240,605 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.